levels stabilized, indicating that viral replication
persisted. This plateau, they say, suggests that the rate at which cells become
infected with newly made virus is approximately equal to the rate at which older
infected cells die. "Unless this quasi-steady state eventually disappears with
longer periods of therapy or can be overcome by the use of more potent therapies
or alternative approaches that block the potential spread of virus within
tissues, HIV-1 may never be eradicated," they write.
"...it is sobering to realize," note Dr. Zhang and his colleagues, "that the
so-called highly active antiretroviral therapy is actually not always active
enough. As we strive to eradicate HIV-1 infection or induce a remission, we
must focus on the possibility of further intensifying antiretroviral treatment,
even though current therapies are already toxic, costly and complex."
One bright spot in this picture, says Carl Dieffenbach, Ph.D., associate
director of the Basic Sciences Program in NIAID's Division of AIDS, is that the
technologies developed by these investigators provide "new tools, so that if we
ever have a patient in whom it appears the virus has been eradicated, we'll be
able to verify that." This ability will become increasingly important, he says,
as new and improved drugs shrink the latent reservoir of HIV even further.
The two studies received additional support from two other components of the
National Institutes of Health (NIH): the National Center for Research Resources,
and the National Heart, Lung and Blood Institute.
'"/>
Contact: Laurie K. Doepel
ldoepel@nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
26-May-1999
Page: 1 2 3 Related biology news :1.
Anti-HIV statisticians win $1.125 million NIH Merit Award2.
Anti-HIV drugs save vision, improve outlook for AIDS patients3.
Image-guided Therapies4.
UCSF Team Identifies Two Key Molecules In Asthma; Important Finding For New Therapies That Treat Disease At Cell Level5.
Genetically Engineered Mice Show Characteristic Signs Of Alzheimers, Could Be Ideal Tool For Testing New Therapies6.
Penn Researchers Prove "Short-Cut" Function Of Myelin Sheath Channel: BetterUnderstanding Of Myelin Should Lead To Therapies For Neuropathies7.
New Insights On Sequence of Cell Death After Brain Injury: Understanding Cellular Events After Brain Trauma Could Lead To Better Therapies8.
Harvard Medical School Researchers Identify Four Human Genes Essential To Cell Division; Discovery Yields New Target For Cancer Therapies9.
Novel AIDS-Directed Technology: Approach Permits Optimization Of Existing Drug Therapies And Targeted, Patient-Specific Treatment10.
Plant-Based Therapies Examined For Colon Cancer Prevention11.
Discovery Could Help Understand Breast-Cancer Therapies